Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519665 | PMC |
| http://dx.doi.org/10.1038/s41392-024-02010-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Miniproteins may have a big impact: new therapeutics for autoimmune diseases and beyond.
Signal Transduct Target Ther
October 2024
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Protecting Encapsulin Nanoparticles with Cysteine-Knot Miniproteins.
Mol Pharm
August 2018
Laboratory for Biomolecular Nanotechnology, MESA+ Institute for Nanotechnology , University of Twente, 7500 AE Enschede , The Netherlands.
A big hurdle for the use of protein-based drugs is that they are easily degraded by proteases in the human body. In an attempt to solve this problem, we show the possibility to functionalize TM encapsulin nanoparticles with an mEETI-II knottin miniprotein from the cysteine-stabilized knot class. The resulting particles did not show aggregation and retained part of their protease inhibitive function.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!